Overview
Zev Rosenwaks, M.D., is the Director and Physician-in-Chief of the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine (CRM). He is Professor of Obstetrics and Gynecology and Reproductive Medicine at Weill Cornell Medical College and Attending Obstetrician-Gynecologist at NewYork-Presbyterian Hospital. In 1994, Dr. Rosenwaks was named the Revlon Distinguished Professor of Reproductive Medicine in Obstetrics and Gynecology. Under his leadership, CRM has become one of the world's leading reproductive endocrinology and assisted reproduction programs.
Dr. Rosenwaks is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. He is a Fellow of the American College of Obstetricians and Gynecologists and is past President of the Society for Reproductive Endocrinology and the Society for Assisted Reproductive Technology. He is currently Vice President of the New York Obstetrical Society.
Dr. Rosenwaks is internationally renowned for his pioneering work in assisted reproduction. He was the director of the Jones Institute for Reproductive Medicine in Norfolk, Virginia, the unit that achieved the first in vitro fertilization (IVF) pregnancy in the United States. He also developed the United States' first egg donation program and has been instrumental in developing many contemporary ovarian stimulation protocols central to successful IVF. He is also a major contributor to moderate stimulation protocols designed to avoid complications such as ovarian hyperstimulation syndrome.
Dr. Rosenwaks' current research interests include developing morphologic and biologic markers of embryo viability in order to enable single embryo transfer and avoid multiple pregnancies; optimizing preimplantation genetic testing; and deriving human embryonic stem cell lines.
Dr. Rosenwaks serves as an Overseer on Weill Cornell Medical College's Board of Overseers and sits on the Faculty Steering Council and Executive Faculty Council at Weill Cornell. He was recently appointed to serve as a Committee Member for the Institute of Medicine of the National Academy of Medicine. Dr. Rosenwaks has trained over 70 fellows and has received the Weill Cornell Medical College Award for Teaching Excellence. He has published over 340 peer-reviewed articles, 100 invited book chapters and 6 textbooks. Dr. Rosenwaks is an Editorial Editor of Fertility and Sterility and an Associate Editor of Seminars in Reproductive Medicine.
Highlights
- 1Human reproduction (Oxford, England) · 2020
- 2Human reproduction (Oxford, England) · 2021
- 3Fertility and sterility · 2020
Publications
Funding
Active
3 grants- Sub-PIPLACER-2023C3-35477Cleavage-stage versus blastocyst-stage embryo transfer in poor prognosis in vitro fertilization patients (PRECiSE trial)Patient-Centered Outcomes Research Institute · 2025–2032 · via Beth Israel Deaconess Medical Center, Inc.
- MPIR61HD123536-01AI-Driven Embryo Selection Platform for Enhanced Implantation in IVF: A Phased Development and Randomized Clinical TrialEunice Kennedy Shriver National Institute of Child Health and Human Development · 2026–2028
- PIDOH01-C37757GG-3450000Infertility Reimbursement ProgramNew York State Department of Health · 2022–2026
Completed grants (2)
- PIDOH01-C33104GG-3450000Infertility Demonstration ProgramNew York State Department of Health · 2017–2022
- KPTRI-SCI 2014-15DNA Helicases as Mediators of Trinucleotide-Repeat Pathology in Fragile X SyndromeTri-Institutional Stem Cell Initiative (Weill Cornell) · 2015–2019 · via Yeshiva University
Clinical research
Active
1 study- PIIMPACT AND SUCCESS RATES IF ASSISTED REPRODUCTIVE TECHNOLOGY AND INFERTILITY TREATMENT: AN ANALYSIS OF THE CENTER FOR REPRODUCTIVE MEDICINE?S CLINICAL DATAWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
Completed & closed trials (1)
- PIImpact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) / COVID-19 on pregnancy and neonatal outcomes in a patient population conceiving with assisted reproductive technology (ART)Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2021)
News mentions
- A Fully Automated AI-Based System for Assessing IVF Embryo QualityOctober 22, 2024
A new artificial intelligence-based system can accurately assess the chromosomal status of in vitro-fertilized (IVF) embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.
- Harnessing Artificial Intelligence Technology for IVF Embryo SelectionDecember 19, 2022
An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes.
- Faulty DNA Repair May Lead to BRCA-Linked CancersNovember 15, 2022
Error-prone DNA replication and repair may lead to mutations and cancer in individuals who inherit a mutant copy of the BRCA1 gene, according to a new study by Weill Cornell Medicine investigators.
- Awards and Honors Across Weill Cornell Medicine: October 30, 2020October 30, 2020
Awards, honors, prizes and achievements for the month of October.
- A Keen Eye: In an IVF Breakthrough, AI Helps Identify the Embryos Most Likely to Lead to Successful PregnanciesJanuary 9, 2020
In an IVF breakthrough, artificial intelligence helps identify the embryos most likely to lead to successful pregnancies.
Show 1 more mention
- Artificial Intelligence Approach Optimizes Embryo Selection for IVFApril 4, 2019
A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy.